| |
|
|
|
Urovant Sciences Ltd  
|
|
9.35 0.52 (0.06%) |
09-24 16:00 |
|
Open: |
8.8 |
Pre close: |
8.83 |
Target:
|
12.03 
|
|
High: |
9.37 |
Low: |
8.37 |
Resistance:
|
10.30
12.03
|
|
Volume: |
84,697 |
Market Cap: |
292M |
Support:
|
8.67
7.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.31
 |
MACD |
MACD(12,26):
|
0.20 |
|
MA(20): |
9.08 |
Signal(12,26,9): |
0.22 |
|
MA(100): |
9.29 |
Stochastic Oscillator |
%K(14,3):
|
35.05 |
|
MA(250): |
10.34 |
%D(3): |
44.72 |
|
Average Volume(K) |
3-Month: |
8214
|
52-Week |
High:
|
15.98 |
|
10-Days: |
7249 |
Low: |
6.55 |
|
RSI |
RSI(14):
|
54.84 |
Change(%): |
-0.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.880 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
31.18 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-113.4 |
Shares Float (M) |
5.85 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
77.32 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
25.99 |
|
Forward EPS |
-4.430 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
856 |
|
Book Value (p.s.) |
-2.750 |
EBITDA (p.s.) |
-4.485 |
P/E |
-1.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.40 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-110.38 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-50.19 |
P/CF |
-2.64 |
|
|
|
|
|
|
